| Amy R Schomer, MD | |
|
1103 W Liberty St, Farmington, MO 63640-1921 | |
| (573) 756-6751 | |
| Not Available |
| Full Name | Amy R Schomer |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1103 W Liberty St, Farmington, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346229010 | NPI | - | NPPES |
| 3062810 | Medicaid | IA | |
| 2062810 | Medicaid | IA | |
| 4062810 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 26803 (Iowa) | Secondary |
| 208000000X | Pediatrics | 24652 (Nebraska) | Secondary |
| 208000000X | Pediatrics | 2016021528 (Missouri) | Primary |
| Entity Name | Physician Groups Lc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285664268 PECOS PAC ID: 3072421254 Enrollment ID: O20040220001157 |
News Archive
Enzon Pharmaceuticals, Inc. today announced the Investigational New Drug (IND) approval by the US Food and Drug Administration (FDA) and plan to commence enrollment into a Phase 1a/1b study shortly. The study will evaluate the safety and tolerability of EZN-4176, the company's novel androgen receptor (AR) mRNA antagonist, for the treatment of patients with castration-resistant prostate cancer (CRPC).
NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for various forms of cancer and other diseases, today announced its second quarter 2010 financial results.
St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) clearance of two spinal cord stimulation tripolar paddle leads for use with the Renew Neurostimulation System.
The Indiana Blood Center in Indianapolis, Indiana, and SMDC Laboratory in Duluth, Minnesota have both chosen to purchase MDS Nordion's Raycell(TM) blood irradiator as a means of eliminating delays in receiving irradiated blood and blood products from external suppliers and improving the service they provide to physicians and patients.
Thunderstorms are common all over the world in summer. As well as spoiling afternoons in the park, lightning, rain and strong winds can damage power grids and cause electricity blackouts.
› Verified 7 days ago
| Entity Name | Parkland Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922016112 PECOS PAC ID: 1951219237 Enrollment ID: O20050224000840 |
News Archive
Enzon Pharmaceuticals, Inc. today announced the Investigational New Drug (IND) approval by the US Food and Drug Administration (FDA) and plan to commence enrollment into a Phase 1a/1b study shortly. The study will evaluate the safety and tolerability of EZN-4176, the company's novel androgen receptor (AR) mRNA antagonist, for the treatment of patients with castration-resistant prostate cancer (CRPC).
NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for various forms of cancer and other diseases, today announced its second quarter 2010 financial results.
St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) clearance of two spinal cord stimulation tripolar paddle leads for use with the Renew Neurostimulation System.
The Indiana Blood Center in Indianapolis, Indiana, and SMDC Laboratory in Duluth, Minnesota have both chosen to purchase MDS Nordion's Raycell(TM) blood irradiator as a means of eliminating delays in receiving irradiated blood and blood products from external suppliers and improving the service they provide to physicians and patients.
Thunderstorms are common all over the world in summer. As well as spoiling afternoons in the park, lightning, rain and strong winds can damage power grids and cause electricity blackouts.
› Verified 7 days ago
| Entity Name | Missouri Baptist Hospital Of Sullivan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295743169 PECOS PAC ID: 2668380148 Enrollment ID: O20060410000616 |
News Archive
Enzon Pharmaceuticals, Inc. today announced the Investigational New Drug (IND) approval by the US Food and Drug Administration (FDA) and plan to commence enrollment into a Phase 1a/1b study shortly. The study will evaluate the safety and tolerability of EZN-4176, the company's novel androgen receptor (AR) mRNA antagonist, for the treatment of patients with castration-resistant prostate cancer (CRPC).
NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for various forms of cancer and other diseases, today announced its second quarter 2010 financial results.
St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) clearance of two spinal cord stimulation tripolar paddle leads for use with the Renew Neurostimulation System.
The Indiana Blood Center in Indianapolis, Indiana, and SMDC Laboratory in Duluth, Minnesota have both chosen to purchase MDS Nordion's Raycell(TM) blood irradiator as a means of eliminating delays in receiving irradiated blood and blood products from external suppliers and improving the service they provide to physicians and patients.
Thunderstorms are common all over the world in summer. As well as spoiling afternoons in the park, lightning, rain and strong winds can damage power grids and cause electricity blackouts.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy R Schomer, MD 1103 W Liberty St, Farmington, MO 63640-1921 Ph: (573) 756-6751 | Amy R Schomer, MD 1103 W Liberty St, Farmington, MO 63640-1921 Ph: (573) 756-6751 |
News Archive
Enzon Pharmaceuticals, Inc. today announced the Investigational New Drug (IND) approval by the US Food and Drug Administration (FDA) and plan to commence enrollment into a Phase 1a/1b study shortly. The study will evaluate the safety and tolerability of EZN-4176, the company's novel androgen receptor (AR) mRNA antagonist, for the treatment of patients with castration-resistant prostate cancer (CRPC).
NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for various forms of cancer and other diseases, today announced its second quarter 2010 financial results.
St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) clearance of two spinal cord stimulation tripolar paddle leads for use with the Renew Neurostimulation System.
The Indiana Blood Center in Indianapolis, Indiana, and SMDC Laboratory in Duluth, Minnesota have both chosen to purchase MDS Nordion's Raycell(TM) blood irradiator as a means of eliminating delays in receiving irradiated blood and blood products from external suppliers and improving the service they provide to physicians and patients.
Thunderstorms are common all over the world in summer. As well as spoiling afternoons in the park, lightning, rain and strong winds can damage power grids and cause electricity blackouts.
› Verified 7 days ago
Dr. Karin L Clauss, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1103 W Liberty St, Farmington, MO 63640 Phone: 573-756-6751 Fax: 573-756-6807 | |
Piyush Srivastava, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1103 W Liberty St, Farmington, MO 63640 Phone: 573-756-6751 | |
Mrs. Jeanne M Kornhardt, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1103 W Liberty St, Farmington, MO 63640 Phone: 573-756-6751 Fax: 573-756-6807 | |
Darlene A Moore, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1103 W Liberty St, Farmington, MO 63640 Phone: 573-756-6751 Fax: 573-756-1965 | |
Ms. Sujatha R Ayyagari, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1103 W Liberty St, Farmington, MO 63640 Phone: 573-756-6751 |